Peer-influenced content. Sources you trust. No registration required. This is HCN.
The Epoch Times
“In light of recent findings, it is crucial to evaluate the implications of modified mRNA in therapeutic uses, particularly its role in immune response and potential cancer progression.”
Allergy & Immunology April 29th 2024
The New England Journal of Medicine
In the case of a 32-year-old patient, a challenging diagnosis of pyoderma gangrenosum associated with aseptic abscess syndrome was established following an intricate evaluation, highlighting the necessity for awareness and precision in diagnosing and managing similar complex cases.
Allergy & Immunology April 15th 2024
The study highlights the persistence of immune imprinting in COVID-19 vaccinated individuals, where the immune response remains skewed towards the original virus, even after booster vaccinations for new variants.
All Specialties April 3rd 2024
Medical Professionals Reference (MPR)
Pemgarda™ emerges as a pivotal development in COVID-19 prophylaxis, particularly for patients with moderate to severe immune compromise, providing a new layer of defense for those less responsive to vaccination.
In a recent study, vaccinated COVID-19 patients showed a 70% mortality rate when hospitalized, surpassing the 37% rate in unvaccinated patients, challenging assumptions about vaccine efficacy in severe cases.
All Specialties March 20th 2024
The linkage between COVID-19 vaccines and sudden sensorineural hearing loss, though rare, underscores the necessity for vigilant monitoring and timely intervention. Understanding the potential autoimmune mechanisms and cochlear vulnerability can aid physicians in better managing and mitigating this distressing side effect.
Allergy & Immunology March 13th 2024